Discoveries made when biology meets computational sciences are revolutionising the landscape of life sciences and healthcare. Computational biology and bioinformatics are driving this transformation helping researchers analyse vast amounts of ...
Read MoreDecipher test results show potential utility in determining benefit of hormone therapy and timing of salvage radiation therapy CHICAGO , May 30, 2015 /PRNewswire/ -- GenomeDx Biosciences today announced that data presented at the 2015 ...
Read MoreSignificant reduction in risk of death observed in those patients with most common risk factors that drive poor outcomes in prostate cancer BOTHELL, Wash. and VANCOUVER, British Columbia , May 30, 2015 /PRNewswire/ -- OncoGenex ...
Read More- The First Three Patients Selected for MET Gene Alterations in MGCD265 Dose Expansion Cohort Show Clear Evidence of Tumor Regression CHICAGO , May 30, 2015 /PRNewswire/ -- Mirati Therapeutics, Inc. ("Mirati") (NASDAQ: MRTX) today presented ...
Read MorePaired Tumor Research in Glioma, Breast Cancer and Epithelial Ovarian Carcinoma Guides Clinical Application of Comprehensive Tumor Profiling IRVING, Texas , May 30, 2015 /PRNewswire/ -- Caris Life Sciences® today announced the presentation ...
Read MoreASCO Presentations Highlight Therapeutic Implications of Similar Genetic Landscape for Brain Metastases in NSCLC, Breast Cancer and Melanoma, as well as Similarities and Differences Between Endometrial, Renal and Ovarian Cancers IRVING, ...
Read MorePhase 3 data (abstract LBA7005) featured in the official press program of the 51st annual meeting of the American Society of Clinical Oncology CHICAGO and RARITAN, N.J. , May 30, 2015 /PRNewswire/ -- Data from the Phase 3 CLL3001 (HELIOS) ...
Read MoreResults from the Phase 2 MMY2002 trial (Abstract LBA8512) featured in the official press program of the 51st Annual Meeting of the American Society of Clinical Oncology (ASCO) CHICAGO and RARITAN, N.J. , May 30, 2015 /PRNewswire/ -- Data ...
Read MoreData featured in today's official press program at American Society of Clinical Oncology Annual Meeting CHICAGO , May 30, 2015 /PRNewswire/ -- Today, Pharmacyclics LLC announced the results of the Phase III HELIOS trial (CLL3001), which ...
Read MoreCHAPEL HILL, N.C. , May 29, 2015 /PRNewswire/ -- The changing healthcare landscape has pushed the medical affairs function into roles involving clinical development, regulatory compliance and market education. As its responsibilities have ...
Read MoreBERGEN, Norway , May 29, 2015 /PRNewswire/ -- BerGenBio AS ("BerGenBio" or the "Company"), an oncology biopharmaceutical company, today announces that an abstract on the latest data on BGB324, the Company's first-in-class, selective small ...
Read MoreNew category of "gluten-free" claims allowed for specially produced oats OTTAWA , May 29, 2015 /CNW/ - To mark Celiac Awareness Month, the Honourable Rona Ambrose, Minister of Health today announced changes that will result in more safe food ...
Read MoreAccording to a nationwide survey by LymeDisease.org, only 7% of chronic Lyme patients are diagnosed and treated within critical thirty-day window essential to cure. More than half wait two years or more for correct diagnosis. SAN FRANCISCO , ...
Read MoreAnpac Discloses 'Breakthrough' Early Cancer Detection 'Blood Biopsy' SACRAMENTO, Calif. , May 29, 2015 /PRNewswire/ -- Anpac Bio-Medical Science Co., Ltd., Chief Executive Officer and Scientist Dr. Chris Yu and the Anpac research team are ...
Read MoreSubscribe to our Free Newsletters!